Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Inv. presentation
Acq. announced
Notes underwriting agrmnt
POSITIVEID Corp (PSID) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/24/2012 GN PositiveID Corporation Comments on Department of Homeland Security's Revised Procurement Strategy for BioWatch Generation 3, Phase II
05/14/2012 GN PositiveID Corporation Collaborates With the University of Nevada to Complete Development of Its Biodosimetry Cartridge for Measuring Radiation
03/16/2012 GN PositiveID Engages Investor Relations Consultant Trilogy Capital Partners
03/05/2012 GN PositiveID Corporation Finalizes First-in-Class Development of a Fully Synthetic Glucose Sensing System, a Critical Component of an Artificial Pancreas
02/21/2012 GN PositiveID Corporation to Present M-BAND at ASM Biodefense and Emerging Diseases Research Meeting February 26-29 in Washington, DC
02/13/2012 GN PositiveID Achieves Positive Preliminary Results From Diabetes Research Institute Study at the University of Miami
02/07/2012 GN PositiveID Corporation Announces Initiation of Clinical Trial of Its Easy Check Non-Invasive Breath Glucose Detection Device
01/05/2012 GN PositiveID Corporation to Launch Clinical Trial of Its Easy Check Non-Invasive Breath Glucose Detection Device This Month
01/03/2012 GN PositiveID Corporation Partners With Diabetes Research Institute at the University of Miami and Schneider Children's Medical Center of Israel to Support Development of PositiveID's Diabetes Management Products
12/19/2011 GN PositiveID Corporation Enters into a Letter of Intent to Sell Non-Core Assets
12/12/2011 GN PositiveID Corporation Announces 2011 Accomplishments and Discusses Outlook for 2012
12/06/2011 GN U.S. Patent and Trademark Office Grants Patent to PositiveID Corporation for Portable Pathogen Detection
11/28/2011 GN PositiveID Corporation Successfully Passes FCC Requirements to Sell Its iglucose System for Diabetes Management in the U.S.
11/15/2011 GN PositiveID Corporation Announces Third Quarter 2011 Highlights
10/26/2011 GN PositiveID Corporation and Development Partner RECEPTORS LLC to Present Their Invention of a Sensing System for an Implantable Glucose Sensor at 11th Annual Diabetes Technology Meeting
10/04/2011 GN Sanofi and the American Medical Directors Association Foundation Sponsor Study Using PositiveID Corporation's iglucose Mobile Health System for Diabetes Management
09/27/2011 GN Diabetes Educators Confirm PositiveID Corporation's iglucose Would Improve Patient Outcomes
09/14/2011 GN PositiveID Corporation Expands Its Biological Detection Capabilities to Address Avian Flu and Other Pandemic Viruses
09/08/2011 GN PositiveID Corporation's iglucose Mobile Health System for Diabetes Management Selected to be Featured at Rogers Wireless Technology Showcase 2011
09/06/2011 GN PositiveID Corporation to Present at International Security and Defense Conference
09/06/2011 GN REMINDER: PositiveID Corporation to Host Investor Call and Webcast on September 7 at 10:00 am ET
08/30/2011 GN PositiveID Corporation Not to Implement a Reverse Stock Split
08/29/2011 GN PositiveID Corporation Appoints William J. Caragol Chief Executive Officer and Bryan Happ Chief Financial Officer
08/24/2011 GN PositiveID Corporation Files Patent for Glucose-Sensing System to be Used in Its GlucoChip Microchip for Patients With Diabetes
08/23/2011 GN PositiveID Corporation Announces Second Quarter 2011 Accomplishments and Mid-Year Update
08/17/2011 GN PositiveID Corporation Successfully Completes Phase II of Its GlucoChip Glucose-Sensing Microchip for Patients With Diabetes
08/11/2011 GN U.S. Department of Homeland Security Validates Performance of PositiveID Corporation's Multiplex BioThreat Assay Through an In-House Blind Study
07/20/2011 GN PositiveID Corporation Awarded Key Patent for Sample Prep of DNA and RNA
07/14/2011 GN PositiveID Corporation Successfully Completes Development of Its Continuous Glucose Sensor to Accurately Measure Glucose Levels in Human Blood
05/31/2011 GN PositiveID Corporation Receives NASDAQ Extension to Regain Compliance With Minimum Bid Price -- 180 Days From Notice Date
05/24/2011 GN PositiveID Corporation Completes Its Acquisition of MicroFluidic Systems, a Leader in Biological Testing and Sample Prep Applications With 29 U.S. Patents and Patents Pending
05/17/2011 GN PositiveID Corporation Files Utility Patent Application for Its Implantable Glucose Sensor to Continuously Monitor Glucose Levels Over an Extended Period of Time
05/12/2011 GN REMINDER: PositiveID Corporation to Host Conference Call and Webcast to Discuss Its Acquisition of MicroFluidic Systems, a Leader in Biological Testing and Sample Prep Applications
05/10/2011 GN PositiveID Corporation Agrees to Acquire MicroFluidic Systems, a Leader in Biological Testing and Sample Prep Applications With 29 U.S. Patents and Patents Pending
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy